SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk

The superoxide dismutase (SOD) is the principal antioxidant defense system in the body that is activated by a reactive oxygen species. Some variants of the <i>SOD2</i> gene have been associated with cancer. The rs4880 variant was determined by PCR real-time and the rs5746136 variant by P...

Full description

Bibliographic Details
Main Authors: Martha P. Gallegos-Arreola, Ramiro Ramírez-Patiño, Josefina Y. Sánchez-López, Guillermo M. Zúñiga-González, Luis E. Figuera, Jorge I. Delgado-Saucedo, Belinda C. Gómez-Meda, Mónica A. Rosales-Reynoso, Ana M. Puebla-Pérez, María L. Lemus-Varela, Asbiel F. Garibaldi-Ríos, Nayely A. Marín-Domínguez, Diana P. Pacheco-Verduzco, Emaan A. Mohamed-Flores
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/44/11/355
_version_ 1827646910905712640
author Martha P. Gallegos-Arreola
Ramiro Ramírez-Patiño
Josefina Y. Sánchez-López
Guillermo M. Zúñiga-González
Luis E. Figuera
Jorge I. Delgado-Saucedo
Belinda C. Gómez-Meda
Mónica A. Rosales-Reynoso
Ana M. Puebla-Pérez
María L. Lemus-Varela
Asbiel F. Garibaldi-Ríos
Nayely A. Marín-Domínguez
Diana P. Pacheco-Verduzco
Emaan A. Mohamed-Flores
author_facet Martha P. Gallegos-Arreola
Ramiro Ramírez-Patiño
Josefina Y. Sánchez-López
Guillermo M. Zúñiga-González
Luis E. Figuera
Jorge I. Delgado-Saucedo
Belinda C. Gómez-Meda
Mónica A. Rosales-Reynoso
Ana M. Puebla-Pérez
María L. Lemus-Varela
Asbiel F. Garibaldi-Ríos
Nayely A. Marín-Domínguez
Diana P. Pacheco-Verduzco
Emaan A. Mohamed-Flores
author_sort Martha P. Gallegos-Arreola
collection DOAJ
description The superoxide dismutase (SOD) is the principal antioxidant defense system in the body that is activated by a reactive oxygen species. Some variants of the <i>SOD2</i> gene have been associated with cancer. The rs4880 variant was determined by PCR real-time and the rs5746136 variant by PCR-RFLP in healthy subjects and in breast cancer (BC) patients. The rs4880 and rs5746136 variants were associated with BC susceptibility when BC patients and the control group were compared for the <i>CT</i>, <i>TT</i>, <i>CTCC</i>, and the T alleles (<i>p</i> < 0.05). The <i>CT</i> genotype of the rs4880 variant showed significant statistical differences in patients and controls aged ≤ 45 years old, and with hormonal consumption (<i>p</i> < 0.05). The rs4880 variant was associated with BC patients with <i>CTTT</i> genotype and obesity, the presence of DM2-SAH, and a non-chemotherapy response (<i>p</i> < 0.05). Additionally, the rs5746136 variant was associated with susceptibility to BC with Ki-67 (≥20%), luminal A type BC, and a chemotherapy partial response (<i>p</i> < 0.05) in BC patients who carry <i>TT</i>, <i>TC</i>, and <i>CTTT</i> genotypes, respectively. The haplotype <i>T/T</i> (OR 1.98; 95% CI 1.20–3.26, <i>p</i> = 0.005) was observed to be a risk factor for BC. The rs4880 and rs5746136 variants in the SOD2 gene were associated with BC susceptibility.
first_indexed 2024-03-09T19:10:00Z
format Article
id doaj.art-165c6bde51044b6591a3c9744e6d1956
institution Directory Open Access Journal
issn 1467-3037
1467-3045
language English
last_indexed 2024-03-09T19:10:00Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj.art-165c6bde51044b6591a3c9744e6d19562023-11-24T04:12:58ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452022-10-0144115221523310.3390/cimb44110355SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer RiskMartha P. Gallegos-Arreola0Ramiro Ramírez-Patiño1Josefina Y. Sánchez-López2Guillermo M. Zúñiga-González3Luis E. Figuera4Jorge I. Delgado-Saucedo5Belinda C. Gómez-Meda6Mónica A. Rosales-Reynoso7Ana M. Puebla-Pérez8María L. Lemus-Varela9Asbiel F. Garibaldi-Ríos10Nayely A. Marín-Domínguez11Diana P. Pacheco-Verduzco12Emaan A. Mohamed-Flores13División de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), 44340 Guadalajara, MexicoDepartamento de Medicina y Ciencias de la Vida, Centro Universitario la Ciénega, Universidad de Guadalajara, 47810 Ocotlán, MexicoDivisión de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), 44340 Guadalajara, MexicoDivisión de Medicina Molecular, CIBO, IMSS, 44340 Guadalajara, MexicoDivisión de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), 44340 Guadalajara, MexicoLaboratorio de Inmunofarmacología, Departamento de Farmacología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, 44100 Guadalajara, MexicoDepartamento de Biología Molecular y Genómica, Instituto de Genética Humana “Dr. Enrique Corona Rivera”, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44100 Guadalajara, MexicoDivisión de Medicina Molecular, CIBO, IMSS, 44340 Guadalajara, MexicoLaboratorio de Inmunofarmacología, Departamento de Farmacología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, 44100 Guadalajara, MexicoDepartamento de Neonatología, Hospital de Pediatría, UMAE, CMNO, IMSS, 44340 Guadalajara, MexicoDoctorado en Genética Humana, IGH, CUCS, Universidad de Guadalajara, 44100 Guadalajara, MexicoDivisión de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), 44340 Guadalajara, MexicoDivisión de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), 44340 Guadalajara, MexicoHospital de Gineco-Obstetricia, UMAE, CMNO, IMSS, 44340 Guadalajara, MexicoThe superoxide dismutase (SOD) is the principal antioxidant defense system in the body that is activated by a reactive oxygen species. Some variants of the <i>SOD2</i> gene have been associated with cancer. The rs4880 variant was determined by PCR real-time and the rs5746136 variant by PCR-RFLP in healthy subjects and in breast cancer (BC) patients. The rs4880 and rs5746136 variants were associated with BC susceptibility when BC patients and the control group were compared for the <i>CT</i>, <i>TT</i>, <i>CTCC</i>, and the T alleles (<i>p</i> < 0.05). The <i>CT</i> genotype of the rs4880 variant showed significant statistical differences in patients and controls aged ≤ 45 years old, and with hormonal consumption (<i>p</i> < 0.05). The rs4880 variant was associated with BC patients with <i>CTTT</i> genotype and obesity, the presence of DM2-SAH, and a non-chemotherapy response (<i>p</i> < 0.05). Additionally, the rs5746136 variant was associated with susceptibility to BC with Ki-67 (≥20%), luminal A type BC, and a chemotherapy partial response (<i>p</i> < 0.05) in BC patients who carry <i>TT</i>, <i>TC</i>, and <i>CTTT</i> genotypes, respectively. The haplotype <i>T/T</i> (OR 1.98; 95% CI 1.20–3.26, <i>p</i> = 0.005) was observed to be a risk factor for BC. The rs4880 and rs5746136 variants in the SOD2 gene were associated with BC susceptibility.https://www.mdpi.com/1467-3045/44/11/355breast cancerROSSOD2variantrs4880rs5746136
spellingShingle Martha P. Gallegos-Arreola
Ramiro Ramírez-Patiño
Josefina Y. Sánchez-López
Guillermo M. Zúñiga-González
Luis E. Figuera
Jorge I. Delgado-Saucedo
Belinda C. Gómez-Meda
Mónica A. Rosales-Reynoso
Ana M. Puebla-Pérez
María L. Lemus-Varela
Asbiel F. Garibaldi-Ríos
Nayely A. Marín-Domínguez
Diana P. Pacheco-Verduzco
Emaan A. Mohamed-Flores
SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk
Current Issues in Molecular Biology
breast cancer
ROS
SOD2
variant
rs4880
rs5746136
title SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk
title_full SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk
title_fullStr SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk
title_full_unstemmed SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk
title_short SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk
title_sort sod2 gene variants rs4880 and rs5746136 and their association with breast cancer risk
topic breast cancer
ROS
SOD2
variant
rs4880
rs5746136
url https://www.mdpi.com/1467-3045/44/11/355
work_keys_str_mv AT marthapgallegosarreola sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT ramiroramirezpatino sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT josefinaysanchezlopez sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT guillermomzunigagonzalez sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT luisefiguera sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT jorgeidelgadosaucedo sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT belindacgomezmeda sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT monicaarosalesreynoso sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT anampueblaperez sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT mariallemusvarela sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT asbielfgaribaldirios sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT nayelyamarindominguez sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT dianappachecoverduzco sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk
AT emaanamohamedflores sod2genevariantsrs4880andrs5746136andtheirassociationwithbreastcancerrisk